SCHEDULE 13D

Company

Cellectar Biosciences, Inc.

Filed

April 25, 2016

Accession Number

0000892712-16-001607

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →